Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Elite controllers: A potential model for a functional HIV cure?
• Guest commentary: Promising novel therapies for CDI and the need for better management strategies
• CDC director highlights lessons learned from Ebola epidemic
• CDC: Flu vaccine matches early strains; 40 million doses distributed
• CDC recommends nursing homes improve antibiotic stewardship
• Daraprim price jump raises concerns among ID groups, providers
• Global antibiotic consumption, resistance rising
• Influenza illness among elderly contingent upon vaccination of younger adults
• Peanut officials draw prison sentences for 2008-2009 Salmonella outbreak
• Pertussis vaccine not protective against B. parapertussis
• Ryan White patients more likely to recieve ART, achieve viral suppression
• Use of OPAT suggests inclusion in antibiotic stewardship program
• WHO early 2016 guidelines expand ART to all HIV-infected patients
• Researchers recommend early ART following START trial results
• Beyond IV to PO switch therapy: Oral antimicrobial therapy Burke A. Cunha, MD, MACP
• The Aedes trio in the Americas — dengue, chikungunya and Zika Thomas M Yuill, PhD; Donald Kaye, MD, MACP
• FDA approves addition of genital swab claim to HSV 1, 2 test
• FDA grants fast track designation for single-dose bacterial vaginosis drug
• Active surveillance significantly reduces SSI rates after neurosurgery
• Age influences efficacy of Prevnar 13
• Asymptomatic bacteriuria treatment leads to greater drug resistance
• Cellphone data track spread of rubella in Kenya
• Early flu treatment shortens hospitalization among seniors
• Hormonal contraceptives, genital tract infections influence cervical immunology
• Housestaff knowledge, application of CAUTI guidelines fall short
• Improved quality of care reduces mortality among HIV patients
• Iron supplementation does not increase malaria risk during pregnancy
• Middle-aged adults show cross-neutralizing antibodies to some flu strains
• N. meningitidis remains susceptible to antibiotics
• Needle exchange in Washington, D.C., averts 120 new HIV cases in 2 years
• New antivirals viable PEP option in HCWs exposed to Ebola
• News reports on Ebola outbreak correspond with surveillance data
• No new infections among HIV PrEP clinical cohort
• Paper medical records unlikely to be contaminated by serious pathogens
• PrEP protects high-risk MSM against HIV-1 infection
• Presence of children in household increases likelihood of viral detection
• Rapid molecular testing for S. aureus optimizes ED antibiotic selection
• Reason for surge in plague cases remains unknown
• Simulated patient visits in India show low adherence to TB guidelines
• Sleep duration influences infection susceptibility
• WNV most common cause of reported neuroinvasive arboviral diseases in 2014
• Antibiotic prescribing increases among nurse practitioners, physician assistants
• CDI nearly doubles mortality, costs among seniors
• Contact lens case changes color to signal bacterial contamination
• High rate of N. gonorrhoeae among MSM growing
• High variance, gaps in global antimicrobial resistance among gram-negative urinary pathogens
• IGNITE1: Eravacycline effective in high-risk patients with cIAI
• Low-cost vaginal ring targets transmission of HIV, STIs
• MODIFY trials demonstrate efficacy of monoclonal antibody treatment for CDI
• Ophthalmology in need of antimicrobial stewardship
• P. falciparum susceptibility to ACT declining in India
• Personality-specific interventions improve infection control adherence
• Prevalence of comorbidities rising among HIV patients
• Reduced cost makes cefazolin ‘appealing’ first-line therapy for MSSA
• Stribild safer, more effective than combination treatment in women with HIV
• Newer therapies to consider for SSTI since 2014 treatment guidelines Kimberly Boeser, PharmD, MPH, BCIDP